Women's Health

The Pharmacy Times® Women’s Health resource center provides clinical news and articles, pertaining to women’s wellness, nutrition, fitness, weight loss, and answers to other potentially more intimate questions.

What can we help you find?
Women Face Obstacles to Pharmacy Ownership, But There Are Opportunities
Although 62% of the first professional degrees in pharmacy were awarded to women in 2017-2018,1 there are only about half as many female pharmacy owners as there are women graduating from pharmacy school.
FDA Approves Generic Fulvestrant Injection for Advanced Breast Cancer
The newly approved therapy is equivalent to AstraZeneca Pharmaceuticals’ Faslodex injection, 250mg/5mL.
Health Care Professionals Can Help Prevent Chlamydia Infections
Due to the large number of people affected, chlamydia has become a global health concern.
Women in Pharmacy: Challenges, Successes, and Support
Attendees at the McKesson ideaShare had the chance to hear about women pharmacists and the challenges, successes, and opportunities they have in a session presented by Suzanne Soliman, PharmD.
New Treatment for HSDD Granted FDA Approval for Premenopausal Women
The effectiveness and safety of bremelanotide were studied in a pair of 24-week, randomized, double-blind, placebo-controlled trials in 1247 premenopausal women with acquired, generalized HSDD.
FDA Approves Drospirenone Tablet for Pregnancy Prevention
A progestin-only pill, this estrogen-free oral contraceptive is intended as a 24 active and 4 inactive tablet dosing regimen.
Prescribing Contraceptives: Oregon Pharmacists Help the Medicaid Population
Contraceptives are both a popular and effective birth control method, and Medicaid fully covers them for its beneficiaries.
Multidisciplinary Approach Recommended for Management of Preexisting Diabetes in Pregnancy
Uncontrolled diabetes in pregnancy can lead to preeclampsia, cesarean delivery, preterm delivery, significant overgrowth in the child, and congenital defects.
Study: Racial Disparities Among Women with HIV
This report revealed that in 2016, an estimated 3900 of 4200 or 93% incident HIV infections among black women would not have occurred if the incidence for black women were the same as that for white women.
Hormone Therapy Combination Now Available for Treating Hot Flashes in Menopausal Women
The commercial availability of Bijuva offers an FDA approved alternative to marketed synthetic hormones or individual estrogen and progesterone products that have not been FDA-approved for combination use. 
New Treatment for Osteoporosis In Postmenopausal Women is Available
Approved by the FDA on April 9, 2019, Amgen’s romosozumab-aqqg therapy (Evenity) is indicated for osteoporosis in postmenopausal women at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other available osteoporosis therapy.
FDA Orders Safety Labeling Changes for Female Sexual Dysfunction Therapy
The action requires the company to revise safety information that women and their health care professionals need when considering use of the drug.
+ Load More